Four faces of cellular senescence
Open accessThe DOI matches its Crossref record; 133 of the 137 references it cites were found in a registry or an index; 10 of the 26 sources its claims cite were checked for support.
Abstract
Cellular senescence is an important mechanism for preventing the proliferation of potential cancer cells. Recently, however, it has become apparent that this process entails more than a simple cessation of cell growth. In addition to suppressing tumorigenesis, cellular senescence might also promote tissue repair and fuel inflammation associated with aging and cancer progression. Thus, cellular senescence might participate in four complex biological processes (tumor suppression, tumor promotion, aging, and tissue repair), some of which have apparently opposing effects. The challenge now is to understand the senescence response well enough to harness its benefits while suppressing its drawbacks.
Overview
CoChat Summary
## TL;DR
Cellular senescence is presented as an essentially irreversible growth arrest that suppresses tumor formation, but the paper argues it also has broader roles in tumor promotion, aging, and tissue repair. The authors frame these effects as arising from the senescence-associated secretory phenotype (SASP) and from the context in which senescent cells accumulate.
## Key findings
- Senescence is described as a crucial anticancer mechanism: in human and mouse premalignant lesions, senescent cells are abundant, but they are “markedly diminished” in the malignant tumors that develop from those lesions.
- Senescent cells can promote tumor progression in mouse xenografts: co-injection of senescent fibroblasts with premalignant epithelial cells enabled malignant cancer formation, and co-injection with fully malignant cells “markedly accelerates” tumor formation.
- Senescent cells may contribute to aging and degeneration: transgenic mice with chronically elevated p53 activity showed “shortened life span and premature aging,” including loss of fertility, osteoporosis, sarcopenia, dermal thinning, loss of subcutaneous fat, reduced hair growth, and retarded wound healing.
- In tissue repair, senescence appears beneficial: after acute liver injury, stellate cells undergo senescence, ECM production declines, MMP secretion increases, and mice impaired for senescence because of p53 or p16INK4a/p19ARF deficiencies developed “severe fibrosis” after injury.
## Methods
- This is a narrative review synthesizing prior studies across human tissues, mouse models, cell culture, and mouse xenografts.
- The paper compares senescent versus nonsenescent cells and summarizes experimental perturbations of p53, p16INK4a/pRB, Pten, Klotho, BubR1, p63, and CCN1 in relation to senescence phenotypes.
- Main analysis is interpretive and mechanistic: the authors connect published findings to a model in which senescence has temporally ordered phases, including early growth arrest, SASP induction, and later immune clearance or tissue-level effects.
## Limitations
- The paper itself states that evidence for senescence driving aging is “circumstantial,” and that cause-and-effect cannot yet be tested cleanly because organisms lacking senescence generally die prematurely of cancer.
- It also notes that there are “no definitive answers” for how senescence might promote late-life cancer.
- Evident from the text: many claims rely on mouse models, cell culture, and xenografts rather than direct demonstration in naturally occurring human disease.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
8 Valid · 1 Not valid · 8 Not checked · 28 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“thus p53 can be pro-aging or pro-longevity, depending on the physiological context (de Keizer et al., 2010).”
§ Four faces of cellular senescence > Cellular senescence and aging > Altered p53 function and aging.
What the sources say
- Supportedcites de Keizer et al., 2010 source
The paper states directly that p53 can be either pro-aging or pro-longevity depending on physiological context. It also explains that p53 can promote or retard aging depending on how its activity is regulated. (LLM, conf=0.95)
plainstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Low-level, chronic, “sterile” inflammation is a hallmark of aging that initiates or promotes most, if not all, major age-related diseases (Franceschi et al., 2007; Chung et al., 2009).”
§ Four faces of cellular senescence > Cellular senescence and aging > How might senescent cells promote age-related pathologies?
What the sources say
- Not checked — no full text of the sourcecites Franceschi et al., 2007 source
- Partly supportedcites Chung et al., 2009 sourceExperimental — accuracy not yet measured
The Introduction describes chronic, low-grade inflammation as a possible link between aging and the pathogenesis of many age-related diseases; the Conclusion calls it a primary factor underlying aging and numerous age-related diseases. The copy does not characterize the inflammation as “sterile,” and its references to many or numerous diseases do not substantiate “most, if not all.” Page numbers were not available in the indexed passages. (LLM, conf=0.86)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“which comprise a negative feedback loop to dampen NF-κB activity (Taganov et al., 2006; Freund et al., 2010).”
What the sources say
- Partly supportedcites Taganov et al., 2006 sourceExperimental — accuracy not yet measured
The Discussion (page not specified in our copy) proposes that NF-κB induces miR-146 genes, which could reduce IRAK1 and TRAF6 levels and thereby dampen pathway activity. The claim presents that proposed negative-feedback effect as established; the paper says further studies are needed to determine miR-146’s exact role. (LLM, conf=0.85)
- Supportedcites Freund et al., 2010 source
The “Chromatin organization” section states that miR-146a/b provide negative feedback that inhibits NF-κB activity. The “microRNAs” section likewise describes them as part of an NF-κB feedback loop. (LLM, conf=0.94)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Whatever the case, the examples above, and a growing list of similar studies (Collado and Serrano, 2010), argue that cellular senescence restrains cancer by imposing a cell-autonomous block to the proliferation of oncogenically damaged/stressed cells (Fig. 2).”
§ Four faces of cellular senescence > Cellular senescence and tumor suppression
What the sources say
- Supportedcites Collado and Serrano, 2010 source
The Introduction (page not provided) describes oncogenically stressed cells stopping division through a cell-cycle arrest and identifies oncogene-induced senescence as a tumour-suppressor mechanism. The Preface adds that senescence stably blocks proliferation and that progression to malignancy requires evading it. (LLM, conf=0.93)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The induction of these miRNAs may prevent the SASP from generating persistent acute (robust) inflammation, which, unlike low-level chronic inflammation, is designed to be self-limiting (Taganov et al., 2006).”
What the sources say
- Partly supportedcites Taganov et al., 2006 sourceExperimental — accuracy not yet measured
The Discussion proposes that induced miR-146 could dampen inflammatory signaling through a negative-feedback loop. It does not address the SASP or establish that these miRNAs prevent it from generating persistent acute inflammation; nor does it make the stated comparison with low-level chronic inflammation. (LLM, conf=0.85)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
30 more claims · 2 with their cited sources checked
Create a free account to see all 45 claims and every source verdict.
- It may state two separate claims as one. 4
- Probably not a substantial claim. 6
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Increased numbers of senescent cells with age are an important contributor to the age-associated increase in inflammation because senescent cells secrete a large number of pro-inflammatory proteins (senescence-associated secretory phenotype, or SASP) (Rodier and Campisi, 2011).”
From The Aging Epigenome (2016) · cites this paper as Rodier and Campisi, 2011
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Senescence can be triggered by multiple mechanisms, including those resulting in ROS production and oxidative stress (Kuilman et al., 2010; Rodier and Campisi, 2011).”
From mTOR inhibition prevents epithelial stem cell senescence and protects from radiation-induced mucositis (2012) · cites this paper as Rodier and Campisi, 2011
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Cells undergoing damage-induced senescence are often cleared by the immune system, as several SASP factors are cytokines and chemokines that can modulate the local immune environment.2,3,5,70,71”
From Paracrine roles of cellular senescence in promoting tumourigenesis (2018) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“which exhibit various senescence-related phenotypes, like increased size of nucleoli, enlarged and overloaded lysosome, and secretion of senescence-associated secretory phenotype (SASP) factors.5,6,7”
From Single-cell senescence identification reveals senescence heterogeneity, trajectory, and modulators (2024) · cites this paper as [6]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Recent findings have uncovered an additional beneficial effect of the senescence response and accompanying SASP: the ability to promote optimal repair of damaged tissue (59, 91, 145–147).”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [147]
23 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219 · cited 2×
“Moreover, to form a lethal tumor, cancer cells must acquire a greatly expanded growth potential and ability to proliferate while expressing activated oncogenes (Hanahan and Weinberg, 2000), traits that are suppressed by the senescence program.”
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477 · cited 2×
“First, senescent cells increase with age in a variety of mammalian tissues (Dimri et al., 1995; Paradis et al., 2001; Melk et al., 2003; Erusalimsky and Kurz, 2005; Jeyapalan et al., 2007; Wang et al., 2009).”
The limited in vitro lifetime of human diploid cell strains
Hayflick, L. (1965) · Experimental Cell Research · doi:10.1016/0014-4827(65)90211-9 · Cited by 5,876
Telomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Extension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441 · cited 2×
“…al., 1991; Shay et al., 1991; Bond et al., 1994; Lin et al., 1998; Schmitt et al., 2002; Beauséjour et al., 2003; Collins and Sedivy, 2003; Oren, 2003; Herbig et al., 2004; Jacobs and de Lange, 2004; Ohtani et al., 2004; Chen et al., 2005; Campisi and d’Adda di Fagagna, 2007; Rodier et al., 2007).”
Self-citationTaganov, K. D., Boldin, M. P., Chang, K.-J., & Baltimore, D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605298103 · Cited by 4,317
Pleiotropy, natural selection, and the evolution of senescence.
Williams, G. C. (1957) · Evolution · doi:10.1111/j.1558-5646.1957.tb02911.x · Cited by 4,279
Cited by
Items 101–200 of 2,013
Monounsaturated Fatty Acids in Obesity-Related Inflammation
Ravaut, G., Légiot, A., Bergeron, K.-F., & Mounier, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010330 · Cited by 249
“It often appears in individuals with poor feeding habits and a sedentary lifestyle, features strongly correlated with obesity development [26,27].”
BackgroundTabibian, J. H., O'Hara, S. P., Splinter, P. L., Trussoni, C. E., & LaRusso, N. F. (2014) · Hepatology · doi:10.1002/hep.26993 · Cited by 241
Aging Hallmarks: The Benefits of Physical Exercise
Rebelo-Marques, A., De Sousa Lages, A., Andrade, R., Ribeiro, C. F., Mota-Pinto, A., Carrilho, F., & Espregueira-Mendes, J. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00258 · Cited by 246
“The secretome of a senescent cell presents dramatic alterations becoming particularly enriched in pro-inflammatory cytokines and matrix metalloproteinases that may contribute to aging (10, 202, 203).”
BackgroundMalaquin, N., Martinez, A., & Rodier, F. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.05.010 · Cited by 247
Self-citationTerlecki-Zaniewicz, L., Lämmermann, I., Latreille, J., Bobbili, M. R., Pils, V., Schosserer, M., Weinmüllner, R., Dellago, H., Skalicky, S., Pum, D., et al. (2018) · Aging · doi:10.18632/aging.101452 · Cited by 246
“Cellular senescence is triggered by various stimuli such as progressive telomere-shortening, hyperoncogenic signaling, accumulation of DNA damage, oxidative stress or mitochondrial dysfunctions, leading to an irreversible growth arrest mediated by the key cell cycle inhibitors CDKN1A and/or CDKN2A [10].”
BackgroundMitochondrial Homeostasis and Cellular Senescence
Vasileiou, P., Evangelou, K., Vlasis, K., Fildisis, G., Panayiotidis, M., Chronopoulos, E., Passias, P.-G., Kouloukoussa, M., Gorgoulis, V., & Havaki, S. (2019) · Cells · doi:10.3390/cells8070686 · Cited by 244
Britschgi, A., Andraos, R., Brinkhaus, H., Klebba, I., Romanet, V., Müller, U., Murakami, M., Radimerski, T., & Bentires-Alj, M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.10.023 · Cited by 240
Mangerich, A., Knutson, C. G., Parry, N. M., Muthupalani, S., Ye, W., Prestwich, E., Cui, L., McFaline, J. L., Mobley, M., Ge, Z., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1207829109 · Cited by 242
“One of the hallmarks of senescence is increased expression of apoptosis-inducing p16 (Cdkn2a) (66), the expression of which is increased significantly in both liver and colon at 20 w p.”
BackgroundInflammation and premature aging in advanced chronic kidney disease
Kooman, J. P., Dekker, M. J., Usvyat, L. A., Kotanko, P., van der Sande, F. M., Schalkwijk, C. G., Shiels, P. G., & Stenvinkel, P. (2017) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00256.2017 · Cited by 240
“A factor that is considered highly important in the pathogenesis of inflammaging is the “senescence-associated secretory phenotype” (SASP), in which senescent cells release proinflammatory cytokines, such as TNF, IL-1, IL-6, and IL-8 (23, 112), which poison the surrounding tissues.”
BackgroundCordycepin prevents radiation ulcer by inhibiting cell senescence via NRF2 and AMPK in rodents
Wang, Z., Chen, Z., Jiang, Z., Luo, P., Liu, L., Huang, Y., Wang, H., Wang, Y., Long, L., Tan, X., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10386-8 · Cited by 219
Qian, R., Ding, L., & Ju, H. (2013) · Journal of the American Chemical Society · doi:10.1021/ja406532e · Cited by 233
Glucocorticoids suppress selected components of the senescence‐associated secretory phenotype
Laberge, R., Zhou, L., Sarantos, M. R., Rodier, F., Freund, A., de Keizer, P. L. J., Liu, S., Demaria, M., Cong, Y., Kapahi, P., et al. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2012.00818.x · Cited by 229
“BRAF and MEK may not lock the senescence state similarly because the amount of DNA damage is too low (Rodier et al., 2011; Tu et al., 2011).”
BackgroundSelf-citationFleury, H., Malaquin, N., Tu, V., Gilbert, S., Martinez, A., Olivier, M.-A., Sauriol, S. A., Communal, L., Leclerc-Desaulniers, K., Carmona, E., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10460-1 · Cited by 228
Self-citationCellular Senescence and the Senescence-Associated Secretory Phenotype as Drivers of Skin Photoaging
Fitsiou, E., Pulido, T., Campisi, J., Alimirah, F., & Demaria, M. (2021) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2020.09.031 · Cited by 227
Self-citationThe Influence of Aging on the Regenerative Potential of Human Adipose Derived Mesenchymal Stem Cells
Marędziak, M., Marycz, K., Tomaszewski, K. A., Kornicka, K., & Henry, B. M. (2016) · Stem Cells International · doi:10.1155/2016/2152435 · Cited by 225
“A reduction in proliferation rate and viability of cells might be ultimately reflected in cell senescence and apoptosis [39].”
The ECM path of senescence in aging: components and modifiers
Levi, N., Papismadov, N., Solomonov, I., Sagi, I., & Krizhanovsky, V. (2020) · The FEBS Journal · doi:10.1111/febs.15282 · Cited by 219
Emerging roles of extracellular vesicles in cellular senescence and aging
Takasugi, M. (2018) · Aging Cell · doi:10.1111/acel.12734 · Cited by 222
“Cellular senescence prevents the proliferation of cells exposed to potentially oncogenic stresses, such as DNA-damaging reagents, irradiation, telomere shortening, and oncogene activation (Kuilman, Michaloglou, Mooi & Peeper, 2010; Rodier & Campisi, 2011).”
BackgroundSeverino, V, Alessio, N., Farina, A., Sandomenico, A., Cipollaro, M., Peluso, G., Galderisi, U., & Chambery, A. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.445 · Cited by 214
“permanent cell growth arrest and impairment of cellular functions.(1,22) The extracellular microenvironment has a key role in regulating and determining the cellular response to”
BackgroundTelomere Length Variations in Aging and Age-Related Diseases
Rizvi, S., Raza, S. T., & Mahdi, F. (2015) · Current Aging Science · doi:10.2174/1874609808666150122153151 · Cited by 207
Coaching from the sidelines: the nuclear periphery in genome regulation
Buchwalter, A., Kaneshiro, J. M., & Hetzer, M. W. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-018-0063-5 · Cited by 206
Marazita, M. C., Dugour, A., Marquioni-Ramella, M. D., Figueroa, J. M., & Suburo, A. M. (2016) · Redox Biology · doi:10.1016/j.redox.2015.11.011 · Cited by 207
“Cellular senescence is a state characterized by an inability to proliferate despite the presence of suf fi cient nutrients and mito-gens while maintaining cell viability and metabolic activity [18,19].”
Senescence-associated lncRNAs: senescence-associated long noncoding RNAs
Abdelmohsen, K., Panda, A., Kang, M.-J., Xu, J., Selimyan, R., Yoon, J.-H., Martindale, J. L., De, S., Wood, W. H., Becker, K. G., et al. (2013) · Aging Cell · doi:10.1111/acel.12115 · Cited by 208
“Many senescent cells also display a characteristic senescence-associated secretory phenotype (SASP; Rodier & Campisi, 2011; Tominaga-Yamanaka et al., 2012); among the secreted factors are numerous cytokines and chemokines [e.g., granulocyte/macrophage colony-stimulating factor (GM-CSF), interleukin…”
BackgroundBarascu, A., Le Chalony, C., Pennarun, G., Genet, D., Imam, N., Lopez, B., & Bertrand, P. (2012) · The EMBO Journal · doi:10.1038/emboj.2011.492 · Cited by 206
“On the other hand, in contrast, beside its putative role in organism ageing, recent data have proposed that senescent cells could favour tumour proliferation or invasion by secreting inflammatory factors (Rodier et al , 2009; Campisi et al , 2011; Rodier and Campisi, 2011).”
A BET family protein degrader provokes senolysis by targeting NHEJ and autophagy in senescent cells
Wakita, M., Takahashi, A., Sano, O., Loo, T. M., Imai, Y., Narukawa, M., Iwata, H., Matsudaira, T., Kawamoto, S., Ohtani, N., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15719-6 · Cited by 206
Takahashi, A., Imai, Y., Yamakoshi, K., Kuninaka, S., Ohtani, N., Yoshimoto, S., Hori, S., Tachibana, M., Anderton, E., Takeuchi, T., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2011.10.018 · Cited by 205
“The interleukins IL-6 and IL-8, major components of the SASP, are of particular interest because these cytokines are known to initiate inflammatory responses associated with many age-related pathologies, including cancer (Rodier and Campisi, 2011).”
BackgroundMicroRNAs linking inflamm-aging, cellular senescence and cancer
Olivieri, F., Rippo, M. R., Monsurrò, V., Salvioli, S., Capri, M., Procopio, A. D., & Franceschi, C. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2013.05.001 · Cited by 205
Lim, H., Park, H., & Kim, H. P. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.06.013 · Cited by 205
Senolytics and senostatics as adjuvant tumour therapy
Short, S., Fielder, E., Miwa, S., & von Zglinicki, T. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.01.056 · Cited by 202
“NF-κB-dependent SASP components are sufficient to aggravate autocrine and paracrine senescence [31,42], however, it appears highly probable that additional factors released from senescent cells including exosomal miRNAs [43,44] and pro-oxidants [30,40,45] may also contribute to senescence-induced bystander senescence.”
BackgroundMicroglia centered pathogenesis in ALS: insights in cell interconnectivity
Brites, D., & Vaz, A. R. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00117 · Cited by 203
“Increase of miR-146a expression was shown to occur in the aged mice (Rodier and Campisi, 2011), as well as after LPS stimulation (Jiang et al., 2012), and is related with the microglia phagocytic potential (Saba et al., 2012).”
BackgroundImmunosenescence, aging and successful aging
Wang, Y., Dong, C., Han, Y., Gu, Z., & Sun, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.942796 · Cited by 201
“However, persistent secretion of SASP may cause chronic systemic inflammation and tissue damage and inhibit immune cell function in the elderly (11, 16).”
BackgroundBecker, L., Nguyen, L., Gill, J., Kulkarni, S., Pasricha, P. J., & Habtezion, A. (2018) · Gut · doi:10.1136/gutjnl-2016-312940 · Cited by 196
Qian, R., Ding, L., Yan, L., Lin, M., & Ju, H. (2014) · Journal of the American Chemical Society · doi:10.1021/ja5042995 · Cited by 195
Inflammaging and Cancer: A Challenge for the Mediterranean Diet
Ostan, R., Lanzarini, C., Pini, E., Scurti, M., Vianello, D., Bertarelli, C., Fabbri, C., Izzi, M., Palmas, G., Biondi, F., et al. (2015) · Nutrients · doi:10.3390/nu7042589 · Cited by 195
“Senescent cells are in fact characterized by the capability to produce high amounts of pro-inflammatory proteins [59,60].”
BackgroundSenescent Cells: Emerging Targets for Human Aging and Age-Related Diseases
Song, S., Lam, E. W.-F., Tchkonia, T., Kirkland, J. L., & Sun, Y. (2020) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2020.03.008 · Cited by 195
“However, some of these senescence-associated molecular and morphological features can also be found in other cell states and/or conditions, such as upregulation of the tumor suppressor p16INK4a, activation of DDR, and changes in heterochromatin [18,19].”
BackgroundImmune System, Cell Senescence, Aging and Longevity - Inflamm-Aging Reappraised
Salvioli, S., Monti, D., Lanzarini, C., Conte, M., Pirazzini, C., Giulia Bacalini, M., Garagnani, P., Giuliani, C., Fontanesi, E., Ostan, R., et al. (2013) · Current Pharmaceutical Design · doi:10.2174/138161213805219531 · Cited by 211
Aging processes and the development of osteoarthritis
Loeser, R. F. (2013) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32835a9428 · Cited by 191
Nucleotide metabolism, oncogene-induced senescence and cancer
Aird, K. M., & Zhang, R. (2015) · Cancer Letters · doi:10.1016/j.canlet.2014.01.017 · Cited by 166
“Senescent cells have unique morphological and molecular characteristics [25].”
MicroRNAs in age‐related diseases
Dimmeler, S., & Nicotera, P. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201201986 · Cited by 188
“Cell senescence is linked to complex changes in cellular morphology, structure and function (Rodier & Campisi, 2011).”
Samuel, M., Fonseka, P., Sanwlani, R., Gangoda, L., Chee, S. H., Keerthikumar, S., Spurling, A., Chitti, S. V., Zanker, D., Ang, C.-S., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24273-8 · Cited by 185
Ohtani, N., & Kawada, N. (2019) · Hepatology Communications · doi:10.1002/hep4.1331 · Cited by 187
“(35,36) In addition, senescent HSCs showing the senescence-associated secretory phenotype (SASP) produce a variety of secreted proteins, such as cytokines, chemokines, and proteases,(37,38) that promote liver tumor progression and are present in an obesity-associated liver tumor microenvironment(13,30) (Fig.”
BackgroundMicroglia regulation of central nervous system myelin health and regeneration
Kent, S. A., & Miron, V. E. (2024) · Nature Reviews Immunology · doi:10.1038/s41577-023-00907-4 · Cited by 183
Liu, P., Li, F., Lin, J., Fukumoto, T., Nacarelli, T., Hao, X., Kossenkov, A. V., Simon, M. C., & Zhang, R. (2021) · Nature Cell Biology · doi:10.1038/s41556-021-00656-3 · Cited by 182
Context-dependent effects of cellular senescence in cancer development.
Lecot, P., Alimirah, F., Desprez, P.-Y., Campisi, J., & Wiley, C. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.115 · Cited by 183
“First, SASP factors support tumour cell invasion and metastasis by disrupting and remodelling tissue structure (Coppe et al, 2008; Rodier and Campisi, 2011).”
BackgroundSelf-citationSenescence in the pathogenesis of age-related macular degeneration
Blasiak, J. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03420-x · Cited by 183
“Senescence has been linked to aging, but this link is not completely clear with several possible pathways [21].”
BackgroundParacrine roles of cellular senescence in promoting tumourigenesis
Gonzalez-Meljem, J. M., Apps, J. R., Fraser, H. C., & Martinez-Barbera, J. P. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0066-1 · Cited by 183
“Senescence was traditionally considered an innate anti-cancer mechanism as it can serve to eliminate damaged cells,(3,5) whereby activation of the senescence programme in cells harbouring oncogenic mutations serves as a tumour suppressor mechanism, preventing the expansion of these mutated cells and progression into m…”
InfluentialAstrocyte senescence promotes glutamate toxicity in cortical neurons
Limbad, C., Oron, T. R., Alimirah, F., Davalos, A. R., Tracy, T. E., Gan, L., Desprez, P.-Y., & Campisi, J. (2020) · PLOS ONE · doi:10.1371/journal.pone.0227887 · Cited by 183
“For example, p16INK4a mRNA was significantly increased in SEN samples (Fig 3B, left panel), while LMNB1 mRNA was significantly decreased (Fig 3B, center panel), and mRNAs encoding SASP factors IL-6, IL-8 and CXCL-1 increased (Fig 3B, right panel).”
BackgroundInfluentialSelf-citationIt's time to redefine inflammation
Antonelli, M., & Kushner, I. (2017) · The FASEB Journal · doi:10.1096/fj.201601326r · Cited by 182
“The lengthy (partially cited here) list includes exposure to environmental irritants such as cigarettes, secondhand smoke, sleep deprivation, low levels of physical activity, atrial fibrillation, hypertension, low birth weight, lumbar disc herniation, impaired cognition, low grip strength, polycystic ovary syndrome, l…”
BackgroundSreekumar, P. G., Ishikawa, K., Spee, C., Mehta, H. H., Wan, J., Yen, K., Cohen, P., Kannan, R., & Hinton, D. R. (2016) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.15-17053 · Cited by 179
Cellular Senescence in Cardiovascular Diseases: A Systematic Review
Hu, C., Zhang, X., Teng, T., Ma, Z.-G., & Tang, Q.-Z. (2022) · Aging and disease · doi:10.14336/ad.2021.0927 · Cited by 174
“Persistent genotoxic stressors trigger DNA damage and activate DDR, which resulting in increased deposition of γ-H2AX and 53BP1 in chromatin [49].”
BackgroundRippe, C., Blimline, M., Magerko, K. A., Lawson, B. R., LaRocca, T. J., Donato, A. J., & Seals, D. R. (2012) · Experimental Gerontology · doi:10.1016/j.exger.2011.10.004 · Cited by 176
“Senescence is associated with the production of inflammatory mediators (Rodier and Campisi, 2011).”
InfluentialPAI-1–regulated extracellular proteolysis governs senescence and survival in Klotho mice
Eren, M., Boe, A. E., Murphy, S. B., Place, A. T., Nagpal, V., Morales-Nebreda, L., Urich, D., Quaggin, S. E., Budinger, G. R. S., Mutlu, G. M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1321942111 · Cited by 176
“A age contributes to the development of frailty and disease in humans, but the fundamental mechanisms that drive physiological aging are incompletely understood (1, 2).”
BackgroundLyu, G., Guan, Y., Zhang, C., Zong, L., Sun, L., Huang, X., Huang, L., Zhang, L., Tian, X.-L., Zhou, Z., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04994-z · Cited by 176
Autophagy drives fibroblast senescence through MTORC2 regulation
Bernard, M., Yang, B., Migneault, F., Turgeon, J., Dieudé, M., Olivier, M.-A., Cardin, G. B., El-Diwany, M., Underwood, K., Rodier, F., et al. (2020) · Autophagy · doi:10.1080/15548627.2020.1713640 · Cited by 173
“Discussion Previous work has shown that autophagy and senescence affect tissue repair that can, in turn, result in fibrosis [6,8,14,41].”
BackgroundSelf-citationBaker, J. R., Vuppusetty, C., Colley, T., Papaioannou, A. I., Fenwick, P., Donnelly, L., Ito, K., & Barnes, P. J. (2016) · Scientific Reports · doi:10.1038/srep35871 · Cited by 175
Senescence in Wound Repair: Emerging Strategies to Target Chronic Healing Wounds
Wilkinson, H. N., & Hardman, M. J. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00773 · Cited by 173
“, 2007) and DNA damage-induced chromatin alterations, including γH2AX and H3K9Me3 (Rodier and Campisi, 2011).”
BackgroundSalminen, A., Kaarniranta, K., & Kauppinen, A. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2012.11.004 · Cited by 173
Hu, W., Sung, T., Jessen, B. A., Thibault, S., Finkelstein, M. B., Khan, N. K., & Sacaan, A. I. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1421 · Cited by 171
“Normal human cells undergo a finite number of divisions before entering a state of irreversible growth arrest termed "replicative senescence," which is triggered by erosion and dysfunction of telomeres (16, 17).”
BackgroundIL-6-STAT3 signaling and premature senescence
Kojima, H., Inoue, T., Kunimoto, H., & Nakajima, K. (2013) · JAK-STAT · doi:10.4161/jkst.25763 · Cited by 170
“SASP also contributes to recruitment of immune cells for clearance of senescent cells, modulates tissue repair, and possibly affects aging of surrounding tissues.(2) In addition to the molecules mentioned above, there are several molecules induced by cytokine signals and involved in the regulation of senescence.”
Background“Social Life” of Senescent Cells: What Is SASP and Why Study It?
Borodkina, A. V., Deryabin, P. I., Giukova, А. А., & Nikolsky, N. N. (2018) · Acta Naturae · doi:10.32607/20758251-2018-10-1-4-14 · Cited by 170
STAT3 regulated ARF expression suppresses prostate cancer metastasis
Pencik, J., Schlederer, M., Gruber, W., Unger, C., Walker, S. M., Chalaris, A., Marié, I. J., Hassler, M. R., Javaheri, T., Aksoy, O., et al. (2015) · Nature Communications · doi:10.1038/ncomms8736 · Cited by 170
SIRT1 suppresses the senescence-associated secretory phenotype through epigenetic gene regulation
Hayakawa, T., Iwai, M., Aoki, S., Takimoto, K., Maruyama, M., Maruyama, W., & Motoyama, N. (2015) · PLOS ONE · doi:10.1371/journal.pone.0116480 · Cited by 170
“SASP exhibits some beneficial functions including tumor suppression, the regulation of tissue repair, such as wound healing, and fibrosis, but also induces tumor progression, inflammation, and tissue degeneration, which promotes cancer, several age-related diseases, and organism aging [40–42].”
BackgroundAging, inflammation and cancer
Bottazzi, B., Riboli, E., & Mantovani, A. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2018.10.011 · Cited by 169
IP3 Receptor-Mediated Calcium Signaling and Its Role in Autophagy in Cancer
Kania, E., Roest, G., Vervliet, T., Parys, J. B., & Bultynck, G. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00140 · Cited by 169
Cellular senescence induced by CD158d reprograms natural killer cells to promote vascular remodeling
Rajagopalan, S., & Long, E. O. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208248109 · Cited by 168
“progression (20) and age-related tissue dysfunction (29)] or beneficial [e.”
BackgroundInfluentialT-cell aging in rheumatoid arthritis
Weyand, C. M., Yang, Z., & Goronzy, J. J. (2014) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000011 · Cited by 164
“The risk for aging-associated outgrowth of cancerous cells is curbed through the cellular senescence program, which forces cells that have undergone repetitive replications into permanent cell cycle arrest [33].”
BackgroundStress-induced biological aging: A review and guide for research priorities
Polsky, L. R., Rentscher, K. E., & Carroll, J. E. (2022) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2022.05.016 · Cited by 165
Mesenchymal Stem Cell Senescence and Rejuvenation: Current Status and Challenges
Zhou, X., Hong, Y., Zhang, H., & Li, X. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00364 · Cited by 167
“The SASP factors include interleukin-1 (IL-1), IL-6, IL8, matrix metalloproteinase1 (MMP1), TNF-α and vascular endothelial growth factor (VEGF) and so on (Rodier and Campisi, 2011).”
BackgroundWeiner‐Gorzel, K., Dempsey, E., Milewska, M., McGoldrick, A., Toh, V., Walsh, A., Lindsay, S., Gubbins, L., Cannon, A., Sharpe, D., et al. (2015) · Cancer Medicine · doi:10.1002/cam4.409 · Cited by 166
“Due to the growth repression feature, cellular senescence is widely regarded as a tumor suppressor mechanism [7].”
BackgroundInfluentialCancer cells enter dormancy after cannibalizing mesenchymal stem/stromal cells (MSCs)
Bartosh, T. J., Ullah, M., Zeitouni, S., Beaver, J., & Prockop, D. J. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1612290113 · Cited by 164
“Paradoxically, senescent cells can also contribute to tumor progression, perhaps through the inflammatory cytokines they produce and/or as a consequence of aging (66).”
BackgroundChorioamniotic membrane senescence: a signal for parturition?
Behnia, F., Taylor, B. D., Woodson, M., Kacerovsky, M., Hawkins, H., Fortunato, S. J., Saade, G. R., & Menon, R. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.05.041 · Cited by 163
DNA damage response (DDR) and senescence: shuttled inflamma-miRNAs on the stage of inflamm-aging
Olivieri, F., Albertini, M. C., Orciani, M., Ceka, A., Cricca, M., Procopio, A. D., & Bonafè, M. (2015) · Oncotarget · doi:10.18632/oncotarget.5899 · Cited by 163
“In higher organisms the DDR is thought to prevent neoplastic transformation in a cell-autonomous manner, by ensuring removal of severely damaged cells [2].”
BackgroundNishimura, K., Kumazawa, T., Kuroda, T., Katagiri, N., Tsuchiya, M., Goto, N., Furumai, R., Murayama, A., Yanagisawa, J., & Kimura, K. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.01.055 · Cited by 163
Alimbetov, D., Davis, T., Brook, A. J. C., Cox, L. S., Faragher, R. G. A., Nurgozhin, T., Zhumadilov, Z., & Kipling, D. (2016) · Biogerontology · doi:10.1007/s10522-015-9610-z · Cited by 162
“…2007) may contribute to the low-level chronic inflammation that is a hallmark of aged mammalian tissues, and provides one route whereby senescent cells can have deleterious effects in the context of ageing (Brassard et al. 2015; Davis and Kipling 2006; Freund et al. 2011; Rodier and Campisi 2011).”
BackgroundThe dynamic biliary epithelia: Molecules, pathways, and disease
O’Hara, S. P., Tabibian, J. H., Splinter, P. L., & LaRusso, N. F. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.10.011 · Cited by 162
“Intriguingly, senescent cells frequently transition to a senescence-associated secretory phenotype (SASP), characterized by the robust secretion of chemokines, cytokines, growth factors, and matrix metalloproteases (MMPs) that function in repair/ remodeling and recruiting of immune cells (reviewed in [64,68]).”
BackgroundStenmark, K. R., Frid, M. G., Graham, B. B., & Tuder, R. M. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy004 · Cited by 162
Senescence and senotherapeutics: a new field in cancer therapy
Myrianthopoulos, V., Evangelou, K., Vasileiou, P. V. S., Cooks, T., Vassilakopoulos, T. P., Pangalis, G. A., Kouloukoussa, M., Kittas, C., Georgakilas, A. G., & Gorgoulis, V. G. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.08.006 · Cited by 160
The causes of replication stress and their consequences on genome stability and cell fate
Magdalou, I., Lopez, B. S., Pasero, P., & Lambert, S. A. E. (2014) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2014.04.035 · Cited by 161
Oncogene-induced senescence results in marked metabolic and bioenergetic alterations
Quijano, C., Cao, L., Fergusson, M. M., Romero, H., Liu, J., Gutkind, S., Rovira, I. I., Mohney, R. P., Karoly, E. D., & Finkel, T. (2012) · Cell Cycle · doi:10.4161/cc.19800 · Cited by 155
A step-by-step microRNA guide to cancer development and metastasis
Markopoulos, G. S., Roupakia, E., Tokamani, M., Chavdoula, E., Hatziapostolou, M., Polytarchou, C., Marcu, K. B., Papavassiliou, A. G., Sandaltzopoulos, R., & Kolettas, E. (2017) · Cellular Oncology · doi:10.1007/s13402-017-0341-9 · Cited by 161
“and restraining excessive SASP activity [117, 145].”
BackgroundInfluentialThe Role of Telomere Biology in Cancer
Xu, L., Li, S., & Stohr, B. A. (2013) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-020712-164030 · Cited by 160
Faces of cellular senescence in skin aging
Ho, C. Y., & Dreesen, O. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111525 · Cited by 158
“, 1995), chromatin and epigenetic modifications (Rodier and Campisi, 2011; Zhang et al., 2007), and resistance to mitogenic (Mathon and Lloyd, 2001) or apoptotic signals (Wang, 1995).”
BackgroundCurcumin: the spicy modulator of breast carcinogenesis
Banik, U., Parasuraman, S., Adhikary, A. K., & Othman, N. H. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0566-5 · Cited by 167
“It prevents aged or abnormal cells from anarchic proliferation and is considered as a potent tumor-suppressing mechanism [72].”
MLL1 is essential for the senescence-associated secretory phenotype
Capell, B. C., Drake, A. M., Zhu, J., Shah, P. P., Dou, Z., Dorsey, J., Simola, D. F., Donahue, G., Sammons, M., Rai, T. S., et al. (2016) · Genes & Development · doi:10.1101/gad.271882.115 · Cited by 156
“Indeed, the SASP is a driving force behind the low-level chronic inflammation that causes or exacerbates many age-related diseases, such as cancer (Rodier and Campisi 2011; Munoz-Espin and Serrano 2014).”
Roles of FGF signaling in stem cell self-renewal, senescence and aging
Coutu, D. L., & Galipeau, J. (2011) · Aging · doi:10.18632/aging.100369 · Cited by 183
“an accumulation of senescent cells in aged tissues[3,5].”
BackgroundIs senescence-associated β-galactosidase a marker of neuronal senescence?
Piechota, M. J., Sunderland, P., Wysocka, A., Nalberczak‐Skóra, M., Śliwińska, M. A., Radwańska, K., & Sikora, E. (2016) · Oncotarget · doi:10.18632/oncotarget.12752 · Cited by 177
“This pro-inflammatory cytokine is also secreted by senescent cells along with other factors which are collectively referred to as senescence-associated secretory phenotype (SASP) [14].”
BackgroundCellular Senescence and the Biology of Aging, Disease, and Frailty
LeBrasseur, N. K., Tchkonia, T., & Kirkland, J. L. (2015) · Nestlé Nutrition Institute Workshop Series · doi:10.1159/000382054 · Cited by 147
Frailty, aging, and periodontal disease: Basic biologic considerations
Clark, D. L., Kotronia, E., & Ramsay, S. E. (2021) · Periodontology 2000 · doi:10.1111/prd.12380 · Cited by 179
Wideł, M., Krzywon, A., Gajda, K., Skonieczna, M., & Rzeszowska‐Wolny, J. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.12.021 · Cited by 162
“Recently, attention has been paid to stress-induced premature senescence [35–38].”
BackgroundExtracellular matrix alterations in senescent cells and their significance in tissue homeostasis
Mavrogonatou, E., Pratsinis, H., Papadopoulou, A., Karamanos, N. K., & Kletsas, D. (2019) · Matrix Biology · doi:10.1016/j.matbio.2017.10.004 · Cited by 153
Sultana, Z., Maiti, K., Dedman, L., & Smith, R. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.11.567 · Cited by 162
Khan, S. Y., Awad, E. M., Oszwald, A., Mayr, M., Yin, X., Waltenberger, B., Stuppner, H., Lipovac, M., Uhrín, P., & Breuss, J. M. (2017) · Scientific Reports · doi:10.1038/srep39501 · Cited by 174
Long non-coding RNA H19 regulates endothelial cell aging via inhibition of STAT3 signalling
Hofmann, P., Sommer, J., Theodorou, K., Kirchhof, L., Fischer, A., Li, Y., Matic, L. P., Hedin, U., Mäegdefessel, L., Dimmeler, S., et al. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy206 · Cited by 159
“The onset of senescence is usually due to telomere shortening and/or DNA damage response pathways.(3) Senescence”
BackgroundSingle-cell senescence identification reveals senescence heterogeneity, trajectory, and modulators
Tao, W., Yu, Z., & Han, J.-D. J. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.03.009 · Cited by 147
Cellular Senescence as the Causal Nexus of Aging
Bhatia‐Dey, N., Kanherkar, R. R., Stair, S. E., Makarev, E., & Csoka, A. B. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00013 · Cited by 168
“Closer analysis reveals that in biological systems, the variability in proliferative capacity of different types of somatic cells from different species is exhibited over a wide range, from very limited to extensive.”
BackgroundInfluentialBiomarkers to identify and isolate senescent cells
Matjusaitis, M., Chin, G., Sarnoski, E. A., & Stolzing, A. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.05.003 · Cited by 144
“Moreover, senescent cells increase in size compared to non-senescent analogues (Kim et al., 2015; Rodier and Campisi, 2011).”
Priming of microglia in a DNA-repair deficient model of accelerated aging
Raj, D. D. A., Jaarsma, D., Holtman, I. R., Olah, M., Ferreira, F. M., Schaafsma, W., Brouwer, N., Meijer, M., de Waard, M. C., van der Pluijm, I., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.03.025 · Cited by 170
“This process most likely activates in fl ammatory pathways and immune responses that target senescent cells in aging tissues for removal (Rodier and Campisi, 2011).”
The multifaceted role of the SASP in atherosclerosis: from mechanisms to therapeutic opportunities
Sun, Y., Wang, X., Liu, T., Zhu, X., & Pan, X. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00815-5 · Cited by 168
Shaping Variation in the Human Immune System
Liston, A., Carr, E. J., & Linterman, M. A. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.08.002 · Cited by 163
DAMPs, ageing, and cancer: The ‘DAMP Hypothesis’
Huang, J., Xie, Y., Sun, X., Zeh, H. J., Kang, R., Lotze, M. T., & Tang, D. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2014.10.004 · Cited by 144
Epigenetic Regulation of Skin Cells in Natural Aging and Premature Aging Diseases
Orioli, D., & Dellambra, E. (2018) · Cells · doi:10.3390/cells7120268 · Cited by 159
“These DNA damage foci co-localize with either telomeric DNA, thus, indicating telomere dysfunction [45], or with PML nuclear bodies that sustain damage-induced senescence growth arrest and inflammatory cytokine secretion [46].”
Background
Metadata
- Authors
- Rodier, F., & Campisi, J.
- Affiliations
- The Research Centre of the University of Montreal Hospital Centre/Institut du Cancer de Montréal, Montreal, Quebec, H2L 4M1 Canada 1
- Buck Institute for Research on Aging (US)
- Corresponding author
- Campisi, Judith
- ORCID
- Campisi, Judith
- Venue
- Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2011-02-14
- Volume
- 192
- Issue
- 4
- Pages
- 547-556
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- PMC
- PMC3044123
- OpenAlex
- W2077450385
- Cited by
- 2,070
- References
- 137
- Citations by year
- 2026: 65 · 2025: 94 · 2024: 101 · 2023: 131 · 2022: 113 · 2021: 164 · 2020: 175 · 2019: 154 · 2018: 164 · 2017: 160 · 2016: 162 · 2015: 162 · 2014: 147 · 2013: 126 · 2012: 108
- FWCI
- 9.92
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Cell Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
- Funders
- U.S. Department of Energy
- Cancer Research Society
- Institut Du Cancer de Montréal
- National Institutes of Health
- National Cancer Institute
- Institute of Cancer Research
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Keywords
- cellular senescence, tumor suppression, tumor promotion, aging, tissue repair, inflammation, tumor progression, senescence-associated secretory phenotype, senescence-associated inflammation
- MeSH terms
- Aging, Animals, Humans, Models, Biological, Neoplasms, Wound Healing, Signal Transduction, Cellular Senescence, Cell Proliferation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.